Xu X - Search Results

1

Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.

Huang Y, Yang Q, Zheng Y, Lin L, Xu X, Xu XE, Silva TC, Hazawa M, Peng L, Cao H, Ding Y, Lu D, Berman BP, Xu LY, Li EM, Yin D. Huang Y, et al. Among authors: xu xe, xu ly, xu x. Nucleic Acids Res. 2021 Sep 20;49(16):9246-9263. doi: 10.1093/nar/gkab679. Nucleic Acids Res. 2021. PMID: 34370013 Free PMC article.

2

Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du ZP, Lv Z, Gu W, Pan F, Xu XE, Xie D, Li EM. Xie JJ, et al. Am J Pathol. 2010 Feb;176(2):939-51. doi: 10.2353/ajpath.2010.090118. Epub 2010 Jan 7. Am J Pathol. 2010. PMID: 20056838 Free PMC article.

3

The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.

Wang WS, Zhong HJ, Xiao DW, Huang X, Liao LD, Xie ZF, Xu XE, Shen ZY, Xu LY, Li EM. Wang WS, et al. Among authors: xu xe, xu ly. Dis Esophagus. 2010 Aug;23(6):512-21. doi: 10.1111/j.1442-2050.2009.01035.x. Epub 2010 Jan 20. Dis Esophagus. 2010. PMID: 20095995

4

Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.

Fang WK, Gu W, Li EM, Wu ZY, Shen ZY, Shen JH, Wu JY, Pan F, Lv Z, Xu XE, Huang Q, Xu LY. Fang WK, et al. Hum Pathol. 2010 Oct;41(10):1456-65. doi: 10.1016/j.humpath.2010.04.003. Hum Pathol. 2010. PMID: 20621329

5

Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma.

Zhao Q, Shen JH, Shen ZY, Wu ZY, Xu XE, Xie JJ, Wu JY, Huang Q, Lu XF, Li EM, Xu LY. Zhao Q, et al. J Histochem Cytochem. 2010 Nov;58(11):979-88. doi: 10.1369/jhc.2010.955765. Epub 2010 Aug 16. J Histochem Cytochem. 2010. PMID: 20713986 Free PMC article.

6

Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma.

Du ZP, Lv Z, Wu BL, Wu ZY, Shen JH, Wu JY, Xu XE, Huang Q, Shen J, Chen HB, Li EM, Xu LY. Du ZP, et al. J Clin Pathol. 2011 Jan;64(1):69-74. doi: 10.1136/jcp.2010.083907. Epub 2010 Nov 25. J Clin Pathol. 2011. PMID: 21109701

7

Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.

Xie JJ, Xu LY, Wu ZY, Zhao Q, Xu XE, Wu JY, Huang Q, Li EM. Xie JJ, et al. J Surg Oncol. 2011 Oct;104(5):538-43. doi: 10.1002/jso.21909. Epub 2011 Mar 17. J Surg Oncol. 2011. PMID: 21416469

8

Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma.

Hou J, Li EM, Shen JH, Qing-Zhao, Wu ZY, Xu XE, Wu JY, Qiao-Huang, Shen J, Guo MZ, Xu LY. Hou J, et al. J Histochem Cytochem. 2011 Jul;59(7):711-8. doi: 10.1369/0022155411409941. Epub 2011 Apr 27. J Histochem Cytochem. 2011. PMID: 21525190 Free PMC article.

9

Expression of ezrin in human embryonic, fetal, and normal adult tissues.

Xie JJ, Zhang FR, Tao LH, Lü Z, Xu XE, Jian-Shen, Xu LY, Li EM. Xie JJ, et al. J Histochem Cytochem. 2011 Nov;59(11):1001-8. doi: 10.1369/0022155411418661. Epub 2011 Aug 10. J Histochem Cytochem. 2011. PMID: 21832146 Free PMC article.

10

Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li TY, Xu LY, Wu ZY, Liao LD, Shen JH, Xu XE, Du ZP, Zhao Q, Li EM. Li TY, et al. Hum Pathol. 2012 Jul;43(7):1068-76. doi: 10.1016/j.humpath.2011.07.027. Epub 2011 Dec 26. Hum Pathol. 2012. PMID: 22204712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,125 results

Search Page

Filters